Drug-Coated Balloon Coronary Angioplasty Versus Stenting for Treatment of Disease Adjacent to a Chronic Total Occlusion. (Co-CTO)

Clinical Trial ID NCT04881812

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04881812

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007 7.61
2 The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation. JACC Cardiovasc Interv 2010 1.72
3 Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. Int J Cardiol 2015 1.01
4 Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol 2013 0.92
5 The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe: The RECHARGE Registry. J Am Coll Cardiol 2016 0.82
6 Impact of drug-eluting stent length on outcomes less is more...more or less. JACC Cardiovasc Interv 2010 0.75
Next 100